Tarrand, Jeffrey

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection

Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 269

Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer

Chitasombat, M. N., Kofteridis, D. P., Jiang, Y., Tarrand, J., Lewis, R. E., & Kontoyiannis, D. P. (2012) · Journal of Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 152

Drug-Resistant Candida glabrata Infection in Cancer Patients

Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2014) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 152

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: A potential benefit from infectious disease consultation

Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 86